Cargando…

Ironing Out the Roles of Macrophages in Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autores principales:	O’Dwyer, David N., Moore, Bethany B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635782/ https://www.ncbi.nlm.nih.gov/pubmed/31091960 http://dx.doi.org/10.1164/rccm.201904-0891ED

Ejemplares similares

The Lung Microbiome in Health, Hypersensitivity Pneumonitis, and Idiopathic Pulmonary Fibrosis: A Heavy Bacterial Burden to Bear
por: O’Dwyer, David N., et al.
Publicado: (2021)

Pharmacological treatment of idiopathic pulmonary fibrosis: time to step out of the comfort zone?
por: Sgalla, Giacomo, et al.
Publicado: (2020)

The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
por: O’Dwyer, David N., et al.
Publicado: (2017)

Erratum: The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes
por: O’Dwyer, David N., et al.
Publicado: (2017)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants
por: Moss, Benjamin J., et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

State of the Art in Idiopathic Pulmonary Fibrosis
por: El Agha, Elie, et al.
Publicado: (2022)

The Role of Surgical Lung Biopsy in Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
por: Limper, Andrew H.
Publicado: (2019)

Autophagy in Idiopathic Pulmonary Fibrosis: Predisposition of the Aging Lung to Fibrosis?
por: Zmijewski, Jaroslaw W., et al.
Publicado: (2022)

Toward Early Detection of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

Ironing out macrophages in atherosclerosis: Ironing out macrophages in atherosclerosis
por: Wang, Lei, et al.
Publicado: (2023)

Macrophage-Derived Biomarkers of Idiopathic Pulmonary Fibrosis
por: Bargagli, E., et al.
Publicado: (2011)

Macrophages: friend or foe in idiopathic pulmonary fibrosis?
por: Zhang, Lei, et al.
Publicado: (2018)

ATP12A: Connecting Mucus and Fibrosis in Idiopathic Pulmonary Fibrosis
por: Zabner, Joseph, et al.
Publicado: (2023)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: accurate diagnosis and early treatment
por: Morais, António
Publicado: (2019)

Guidelines or guidance for better idiopathic pulmonary fibrosis management?
por: Behr, Jürgen
Publicado: (2016)

Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten
por: Maher, Toby M.
Publicado: (2021)

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?
por: Morice, Alyn H.
Publicado: (2022)

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Schupp, Jonas Christian, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
por: Baldi, Bruno Guedes
Publicado: (2017)

Six-minute walk test in patients with idiopathic pulmonary fibrosis
por: Baddini-Martinez, José Antônio
Publicado: (2018)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis
por: Poletti, Venerino
Publicado: (2014)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Assessing the Burden and Prognostic Value of Cough in Idiopathic Pulmonary Fibrosis
por: Johnston, Janet, et al.
Publicado: (2023)

Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
por: Polverino, Francesca
Publicado: (2023)

Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary Fibrosis
por: Moore, Bethany B., et al.
Publicado: (2014)

Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis
por: Molina-Molina, Maria
Publicado: (2019)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Finding Similarities within Differences
por: Reyfman, Paul A., et al.
Publicado: (2019)

Lost in Translation: Endoplasmic Reticulum–Mitochondria Crosstalk in Idiopathic Pulmonary Fibrosis
por: Bueno, Marta, et al.
Publicado: (2020)

Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Call to Arms
por: Kreuter, Michael, et al.
Publicado: (2020)

Do Circulating Monocytes Promote and Predict Idiopathic Pulmonary Fibrosis Progression?
por: Fernandez, Isis E., et al.
Publicado: (2021)

Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?
por: Maher, Toby M.
Publicado: (2021)

Uncovering the Epidemiology of Idiopathic Pulmonary Fibrosis in the Veterans Affairs Health System
por: Tighe, Robert M., et al.
Publicado: (2022)

Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?
por: Hadda, Vijay, et al.
Publicado: (2020)

PRS-ing Forward to Identify Genetic Risk in Idiopathic Pulmonary Fibrosis
por: Blackwell, Timothy S., et al.
Publicado: (2023)

The Challenging Road of Moving from Association to Causation for Microbiome Research in Idiopathic Pulmonary Fibrosis
por: Segal, Leopoldo N., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1coekhimn3lildo9j27s4fdui5